Systematic integration of biomedical knowledge prioritizes drugs for repurposing

eLife

Volumn 6, Issue , 2017, Pages

  Himmelstein, Daniel Scott ^a,b   Lizee, Antoine ^c,d   Hessler, Christine ^c   Brueggeman, Leo ^c,e   Chen, Sabrina L ^c,f   Hadley, Dexter ^a,c   Green, Ari ^c   Khankhanian, Pouya ^b,c   Baranzini, Sergio E ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ DE NANTES   (France)

^e UNIVERSITY OF IOWA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG REPOSITIONING; EPILEPSY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MAPPING; GENE ONTOLOGY; GENE OVEREXPRESSION; GENE SILENCING; MACHINE LEARNING; REAL TIME POLYMERASE CHAIN REACTION; TOBACCO DEPENDENCE; TRANSCRIPTION REGULATION; UPREGULATION; BIOLOGICAL MODEL; BIOLOGY; DRUG DEVELOPMENT; HUMAN; PROCEDURES; SYSTEMS BIOLOGY;

COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; DRUG REPOSITIONING; HUMANS; MODELS, BIOLOGICAL; SYSTEMS BIOLOGY;

EID: 85032925956     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.26726     Document Type: Article

References (243)

1. Allison DB, Brown AW, George BJ, Kaiser KA. 2016. Reproducibility: A tragedy of errors. Nature 530:27-29. DOI: https://doi.org/10.1038/530027a, PMID: 26842041
2. Ashare RL, Kimmey BA, Rupprecht LE, Bowers ME, Hayes MR, Schmidt HD. 2016. Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers. Translational Psychiatry 6:e713. DOI: https://doi.org/10.1038/tp.2015.209, PMID: 26784967
3. Ashburn TT, Thor KB. 2004. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery 3:673-683. DOI: https://doi.org/10.1038/nrd1468, PMID: 15286734
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene Ontology: tool for the unification of biology. Nature Genetics 25:25-29. DOI: https://doi.org/10.1038/75556
5. Baggerly K. 2010. Disclose all data in publications. Nature 467:401. DOI: https://doi.org/10.1038/467401b, PMID: 20864982
6. Balaur I, Mazein A, Saqi M, Lysenko A, Rawlings CJ, Auffray C. 2016. Recon2Neo4j: applying graph database technologies for managing comprehensive genome-scale networks. Bioinformatics 33:1096-1098. DOI: https://doi.org/10.1093/bioinformatics/btw731
7. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. 2013. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Research 41:D991-D995. DOI: https://doi.org/10.1093/nar/gks1193, PMID: 23193258
8. Bastian F, Parmentier G, Roux J, Moretti S, Laudet V, Robinson-Rechavi M. 2008. Data Integration in the Life Sciences: 5th International Workshop, DILS 2008. Bgee: Integrating and Comparing Heterogeneous Transcriptome Data Among Species:124-131. DOI: https://doi.org/10.1007/978-3-540-69828-9_12
9. Beaulieu-Jones BK, Greene CS. 2017. Reproducibility of computational workflows is automated using continuous analysis. Nature Biotechnology 35:342-346. DOI: https://doi.org/10.1038/nbt.3780, PMID: 28288103
10. Belmann P, Dröge J, Bremges A, McHardy AC, Sczyrba A, Barton MD. 2015. Bioboxes: standardised containers for interchangeable bioinformatics software. GigaScience 4:47. DOI: https://doi.org/10.1186/s13742-015-0087-0, PMID: 26473029
11. Bodenreider O. 2004. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Research 32:267D-270. DOI: https://doi.org/10.1093/nar/gkh061, PMID: 14681409
12. Boshier A, Wilton LV, Shakir SA. 2003. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. European Journal of Clinical Pharmacology 59: 767-773. DOI: https://doi.org/10.1007/s00228-003-0693-0, PMID: 14615857
13. Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS. 2016. Mining retrospective data for virtual prospective drug repurposing: l-dopa and age-related macular degeneration. The American Journal of Medicine 129:292-298. DOI: https://doi.org/10.1016/j.amjmed.2015.10.015, PMID: 26524704
14. Brown AS, Patel CJ. 2017. A standard database for drug repositioning. Scientific Data 4:170029. DOI: https://doi.org/10.1038/sdata.2017.29, PMID: 28291243
15. Burbidge JB, Magee L, Robb AL, Leslie Robb A. 1988. Alternative transformations to handle extreme values of the dependent variable. Journal of the American Statistical Association 83:123-127. DOI: https://doi.org/10.1080/01621459.1988.10478575
16. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. 2016. Nicotine receptor partial agonists for smoking cessation. The Cochrane Database of Systematic Reviews 9:CD006103.
17. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. 2008. Drug target identification using side-effect similarity. Science 321:263-266. DOI: https://doi.org/10.1126/science.1158140, PMID: 18621671
18. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, Schultz N, Bader GD, Sander C. 2011. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Research 39:D685-D690. DOI: https://doi.org/10.1093/nar/gkq1039, PMID: 21071392
19. Chambers J, Davies M, Gaulton A, Hersey A, Velankar S, Petryszak R, Hastings J, Bellis L, McGlinchey S, Overington JP. 2013. UniChem: a unified chemical structure cross-referencing and identifier tracking system. Journal of Cheminformatics 5:3. DOI: https://doi.org/10.1186/1758-2946-5-3, PMID: 23317286
20. Chambers J, Davies M, Gaulton A, Papadatos G, Hersey A, Overington JP. 2014. UniChem: extension of InChI-based compound mapping to salt, connectivity and stereochemistry layers. Journal of Cheminformatics 6:43. DOI: https://doi.org/10.1186/s13321-014-0043-5, PMID: 25221628
21. Chen PP-S. 1997. English, Chinese and ER diagrams. Data & Knowledge Engineering 23:5-16. DOI: https://doi. org/10.1016/S0169-023X(97)00017-7
22. Chen X, Liu M, Gilson MK. 2001. BindingDB: a web-accessible molecular recognition database. Combinatorial chemistry & high throughput screening 4:719-725. DOI: https://doi.org/10.2174/1386207013330670, PMID: 11812264
23. Cheng J, Yang L, Kumar V, Agarwal P. 2014. Systematic evaluation of connectivity map for disease indications. Genome Medicine 6:540. DOI: https://doi.org/10.1186/s13073-014-0095-1, PMID: 25606058
24. Chiang AP, Butte AJ. 2009. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clinical Pharmacology & Therapeutics 86:507-510. DOI: https://doi.org/10.1038/clpt.2009.103, PMID: 1 9571805
25. Dailey JW, Naritoku DK. 1996. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochemical Pharmacology 52:1323-1329. DOI: https://doi.org/10.1016/S0006-2952(96)00509-6, PMID: 8937441
26. Dice LR. 1945. Measures of the amount of ecologic association between species. Ecology 26:297-302. DOI: https://doi.org/10.2307/1932409
27. DiMasi JA, Grabowski HG, Hansen RW. 2016. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of HealTheconomics 47:20-33.
28. DOI: https://doi.org/10.1016/j.jhealeco.2016.01.012, PMID: 2692 8437
29. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30:207-210. DOI: https://doi.org/10.1093/nar/30.1.207, PMID: 11752295
30. Ehrenberg HR, Shin J, Ratner AJ, Fries JA, Ré C. 2016. Data Programming with DDLite. Proceedings of the Workshop on Human-in-the-Loop Data Analytics-HILDA’ 16: 1-6.
31. Elliott R. 2005. Who owns scientific data? The impact of intellectual property rights on the scientific publication chain. Learned Publishing 18:91-94. DOI: https://doi.org/10.1087/0953151053584984
32. Fabregat A, Sidiropoulos K, Garapati P, Gillespie M, Hausmann K, Haw R, Jassal B, Jupe S, Korninger F, McKay S, Matthews L, May B, Milacic M, Rothfels K, Shamovsky V, Webber M, Weiser J, Williams M, Wu G, Stein L, et al. 2016. The reactome pathway knowledgebase. Nucleic Acids Research 44:D481-D487. DOI: https://doi. org/10.1093/nar/gkv1351, PMID: 26656494
33. Farook JM, Krazem A, Lewis B, Morrell DJ, Littleton JM, Barron S. 2008. Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in swiss webster mice. Physiology & Behavior 95:267-270. DOI: https://doi.org/10.1016/j.physbeh.2008.05.020, PMID: 18577392
34. Fisher RA. 1922. On the interpretation of c 2 from contingency tables, and the calculation of P. Journal of the Royal Statistical Society 85:87. DOI: https://doi.org/10.2307/2340521
35. Giles J. 2012. Going paperless: The digital lab. Nature 481:430-431. DOI: https://doi.org/10.1038/481430a, PMID: 22281576
36. Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J. 2016. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Research 44:D1045-D1053. DOI: https://doi.org/10.1093/nar/gkv1072, PMID: 26481362
37. Gligorijević V, Pržulj N. 2015. Methods for biological data integration: perspectives and challenges. Journal of the Royal Society Interface 12:20150571.DOI: https://doi.org/10.1098/rsif.2015.0571
38. Gottlieb A, Stein GY, Ruppin E, Sharan R. 2011. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Molecular Systems Biology 7:496. DOI: https://doi.org/10.1038/msb. 2011.26, PMID: 21654673
39. Guney E, Menche J, Vidal M, Bará basi AL. 2016. Network-based in silico drug efficacy screening. Nature Communications 7:10331. DOI: https://doi.org/10.1038/ncomms10331, PMID: 26831545
40. Hadley D, Pan J, El-Sayed O, Aljabban J, Aljabban I, Azad TD, Hadied MO, Raza S, Rayikanti BA, Chen B, Paik H, Aran D, Spatz J, Himmelstein D, Panahiazar M, Bhattacharya S, Sirota M, Musen MA, Butte AJ. 2017. Precision annotation of digital samples in NCBI’s gene expression omnibus. Scientific Data 4:170125. DOI: https://doi.org/10.1038/sdata.2017.125, PMID: 28925997
41. Hagedorn G, Mietchen D, Morris RA, Agosti D, Penev L, Berendsohn WG, Hobern D. 2011. Creative Commons licenses and the non-commercial condition: Implications for the re-use of biodiversity information. ZooKeys: 127-149. DOI: https://doi.org/10.3897/zookeys.150.2189, PMID: 22207810
42. Hanhijärvi S, Garriga GC, Puolamäki K. 2009. Randomization Techniques for Graphs. In: Proceedings of the 2009 SIAM International Conference on Data Mining. DOI: https://doi.org/10.1137/1.9781611972795.67
43. Harmey D, Griffin PR, Kenny PJ. 2012. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine & Tobacco Research 14:1300-1318. DOI: https://doi.org/10.1093/ntr/nts201, PMID: 23024249
44. Have CT, Jensen LJ. 2013. Are graph databases ready for bioinformatics? Bioinformatics 29:3107-3108. DOI: https://doi.org/10.1093/bioinformatics/btt549, PMID: 24135261
45. Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. 2014. Clinical development success rates for investigational drugs. Nature Biotechnology 32:40-51. DOI: https://doi.org/10.1038/nbt.2786, PMID: 24406927
46. Hays JT, Ebbert JO, Sood A. 2008. Efficacy and safety of varenicline for smoking cessation. The American Journal of Medicine 121:S32-S42. DOI: https://doi.org/10.1016/j.amjmed.2008.01.017, PMID: 18342165
47. Heller S, McNaught A, Stein S, Tchekhovskoi D, Pletnev I. 2013. InChI-the worldwide chemical structure identifier standard. Journal of Cheminformatics 5:7. DOI: https://doi.org/10.1186/1758-2946-5-7, PMID: 23343401
48. Hersey A, Chambers J, Bellis L, Patrícia Bento A, Gaulton A, Overington JP. 2015. Chemical databases: curation or integration by user-defined equivalence? Drug Discovery Today: Technologies 14:17-24. DOI: https://doi. org/10.1016/j.ddtec.2015.01.005
49. Hilton EJ, Hosking SL, Betts T. 2004. The effect of antiepileptic drugs on visual performance. Seizure 13:113-128. DOI: https://doi.org/10.1016/S1059-1311(03)00082-7, PMID: 15129841
50. Himmelstein D, Bastian F, Baranzini S. 2016f. Dhimmel/Bgee V1.0: Anatomy-Specific Gene Expression In Humans From Bgee. Zenodo. https://doi.org/10.5281/zenodo.47157
51. Himmelstein D, Bastian F, Hadley D, Greene C. 2015a. STARGEO: Expression Signatures for Disease Using Crowdsourced GEO Annotation. ThinkLab. https://doi.org/10.15363/thinklab.d96 [Accessed September 11, 2017].
52. Himmelstein D, Bastian F. 2015e. Processing Bgee for tissue-specific gene presence and over/under-expression. ThinkLab. https://doi.org/10.15363/thinklab.d124 [Accessed September 11, 2017].
53. Himmelstein D, Bastian F. 2015f. Tissue-specific gene expression resources. ThinkLab. https://doi.org/10.15363/thinklab.d81 [Accessed September 11, 2017].
54. Himmelstein D, Brueggeman L, Baranzini S. 2015q. Pairwise molecular similarities between DrugBank compounds. Figshare. https://doi.org/10.6084/m9.figshare.1418386 [Accessed September 11, 2017].
55. Himmelstein D, Brueggeman L, Baranzini S. 2016k. Consensus signatures for LINCS L1000 perturbations. Figshare. DOI: https://doi.org/10.6084/m9.figshare.3085426.v1
56. Himmelstein D, Brueggeman L, Baranzini S. 2016m. Dhimmel/Lincs V2.0: Refined Consensus Signatures From Lincs L1000. Zenodo. DOI: https://doi.org/10.5281/zenodo.47223
57. Himmelstein D, Brueggeman L, Baranzini S. 2016n. l1000.db: SQLite database of LINCS L1000 metadata. Figshare. DOI: https://doi.org/10.6084/m9.figshare.3085837.v1
58. Himmelstein D, Brueggeman L, Baranzini S. 2017b. Figshare depositions from Project Rephetio. Figshare. DOI: https://doi.org/10.6084/m9.figshare.c.2861359.v1
59. Himmelstein D, Chen S. 2015k. Calculating molecular similarities between DrugBank compounds. ThinkLab. https://doi.org/10.15363/thinklab.d70 [Accessed September 11, 2017].
60. Himmelstein D, Chung C. 2015q. Computing consensus transcriptional profiles for LINCS L1000 perturbations. ThinkLab. https://doi.org/10.15363/thinklab.d43 [Accessed September 11, 2017].
61. Himmelstein D, Fortney K, Knox C. 2016r. Christopher Southan Sounding the alarm on DrugBank’s new license and terms of use. ThinkLab. https://doi.org/10.15363/thinklab.d213 [Accessed September 11, 2017].
62. Himmelstein D, Gilson M, Baranzini S. 2015d. Processing The October 2015 Bindingdb. Zenodo.https://doi.org/10.5281/zenodo.33987
63. Himmelstein D, Gilson M. 2015i. Integrating drug target information from BindingDB. ThinkLab. https://doi.org/10.15363/thinklab.d53 [Accessed September 11, 2017].
64. Himmelstein D, Good B, Khankhanian P, Ratner A. 2016b. Brainstorming future directions for Hetionet. ThinkLab. https://doi.org/10.15363/thinklab.d227 [Accessed September 11, 2017].
65. Himmelstein D, Good B, Oprea T, McCoy A, Lizee A. 2015e. How should we construct a catalog of drug indications? ThinkLab. https://doi.org/10.15363/thinklab.d21 [Accessed September 11, 2017].
66. Himmelstein D, Greene C, Baranzini S. 2015b. Renaming “Heterogeneous Networks” to a More Concise and Catchy Term. ThinkLab. https://doi.org/10.15363/thinklab.d104 [Accessed September 11, 2017].
67. Himmelstein D, Greene C, Jensen LJ. 2016o. Positive correlations between knockdown and overexpression profiles from LINCS L1000. ThinkLab. https://doi.org/10.15363/thinklab.d171 [Accessed September 11, 2017].
68. Himmelstein D, Greene C, Malladi V, Bastian F, Baranzini S. 2015f. Gene-Ontology: Initial Zenodo Release. Zenodo. https://doi.org/10.5281/zenodo.21711
69. Himmelstein D, Greene C, Malladi V, Bastian F. 2015g. Compiling Gene Ontology annotations into an easy-to-use format. ThinkLab. https://doi.org/10.15363/thinklab.d39 [Accessed September 11, 2017].
70. Himmelstein D, Greene C, Pico A. 2015h. Using Entrez Gene as our gene vocabulary. ThinkLab. https://doi.org/10.15363/thinklab.d34 [Accessed September 11, 2017].
71. Himmelstein D, Hadley D, Schepanovski A. 2016j. Dhimmel/Stargeo V1.0: Differentially Expressed Genes For 48 Diseases From Stargeo. Zenodo. DOI: https://doi.org/10.5281/zenodo.46866
72. Himmelstein D, Hadley D, Strokach A. 2015z. Creating a catalog of protein interactions. ThinkLab. https://doi. org/10.15363/thinklab.d85 [Accessed September 11, 2017].
73. Himmelstein D, Hessler C, Khankhanian P. 2016a. Predictions of whether a compound treats a disease. ThinkLab. https://doi.org/10.15363/thinklab.d203 [Accessed September 11, 2017].
74. Himmelstein D, Jensen LJ, Khankhanian P. 2016c. Data nomenclature: naming and abbreviating our network types. ThinkLab. https://doi.org/10.15363/thinklab.d162 [Accessed September 11, 2017].
75. Himmelstein D, Jensen LJ, Smith M, Fortney K, Chung C. 2015i. Integrating resources with disparate licensing into an open network. ThinkLab. https://doi.org/10.15363/thinklab.d107 [Accessed September 11, 2017].
76. Himmelstein D, Jensen LJ. 2015g. Gene-Tissue Relationships From The Tissues Database. Zenodo. DOI: https://doi.org/10.5281/zenodo.27244
77. Himmelstein D, Jensen LJ. 2015h. The TISSUES resource for the tissue-specificity of genes. ThinkLab. https://doi. org/10.15363/thinklab.d91 [Accessed September 11, 2017].
78. Himmelstein D, Jensen LJ. 2015l. Processing the DISEASES resource for disease-gene relationships. ThinkLab. https://doi.org/10.15363/thinklab.d106 [Accessed September 11, 2017].
79. Himmelstein D, Jensen LJ. 2015u. One network to rule them all. ThinkLab. https://doi.org/10.15363/thinklab.d102 [Accessed September 11, 2017].
80. Himmelstein D, Keough K, Vysotskiy M, Kim J, Norgeot B, Cluceru J, Imperial M, Chen E, Sodhi J, Levy E. 2016t. Workshop to analyze LINCS data for the Systems Pharmacology course at UCSF. ThinkLab. https://doi.org/10.15363/thinklab.d181 [Accessed September 11, 2017].
81. Himmelstein D, Khankhanian P, Hessler C. 2015j. Expert curation of our indication catalog for disease-modifying treatments. ThinkLab. https://doi.org/10.15363/thinklab.d95 [Accessed September 11, 2017].
82. Himmelstein D, Khankhanian P, Hessler CS, Green AJ, Baranzini S. 2016p. PharmacotherapyDB 1.0: the open catalog of drug therapies for disease. Figshare. DOI: https://doi.org/10.6084/m9.figshare.3103054
83. Himmelstein D, Khankhanian P, Lizee A. 2016s. Transforming DWPCs for hetnet edge prediction. ThinkLab. https://doi.org/10.15363/thinklab.d193 [Accessed September 11, 2017].
84. Himmelstein D, Khankhanian P, Pico A, Jensen LJ, Morris S. 2017a. Visualizing the top epilepsy predictions in Cytoscape. ThinkLab. https://doi.org/10.15363/thinklab.d230 [Accessed September 11, 2017].
85. Himmelstein D, Khare R. 2015s. Processing LabeledIn to extract indications. ThinkLab. https://doi.org/10.15363/thinklab.d46 [Accessed September 11, 2017].
86. Himmelstein D, Li TS. 2015d. Unifying disease vocabularies. ThinkLab. https://doi.org/10.15363/thinklab.d44 [Accessed September 11, 2017].
87. Himmelstein D, Lizee A, Hessler C, Brueggeman L, Chen S, Hadley D, Green A, Khankhanian P, Baranzini S. 2015k. Rephetio: Repurposing drugs on a hetnet [proposal]. ThinkLab. https://doi.org/10.15363/thinklab.a5 [Accessed September 11, 2017].
88. Himmelstein D, Lizee A, Hessler C, Brueggeman L, Chen S, Hadley D, Green A, Khankhanian P, Baranzini S. 2016v. Rephetio: Repurposing drugs on a hetnet [report]. ThinkLab. https://doi.org/10.15363/thinklab.a7 [Accessed September 11, 2017].
89. Himmelstein D, Lizee A, Hessler C, Brueggeman L, Chen S, Hadley D, Green A, Khankhanian P. 2015c. Sergio Baranzini Rephetio: Repurposing Drugs on a hetnet [project]. ThinkLab. http://dx.doi.org/10.15363/thinklab.4 [Accessed September 11, 2017].
90. Himmelstein D, Lizee A. 2016a. Computing standardized logistic regression coefficients. ThinkLab. https://doi. org/10.15363/thinklab.d205 [Accessed September 11, 2017].
91. Himmelstein D, Lizee A. 2016t. Estimating the complexity of hetnet traversal. ThinkLab. https://doi.org/10.15363/thinklab.d187 [Accessed September 11, 2017].
92. Himmelstein D, Lizee A. 2016v. Measuring user contribution and content creation. ThinkLab. https://doi.org/10.15363/thinklab.d200 [Accessed September 11, 2017].
93. Himmelstein D, Pankov A. 2015a. Mining knowledge from MEDLINE articles and their indexed MeSH terms. ThinkLab. https://doi.org/10.15363/thinklab.d67 [Accessed September 11, 2017].
94. Himmelstein D, Partha R. 2015r. Selecting informative ERC (evolutionary rate covariation) values between genes. ThinkLab. https://doi.org/10.15363/thinklab.d57 [Accessed September 11, 2017].
95. Himmelstein D, Protein SC. 2015j. Protein (target, carrier, transporter, and enzyme) interactions in DrugBank. ThinkLab. https://doi.org/10.15363/thinklab.d65 [Accessed September 11, 2017].
96. Himmelstein D, Sirota M, Way G. 2015v. Calculating genomic windows for GWAS lead SNPs. ThinkLab. https://doi.org/10.15363/thinklab.d71 [Accessed September 11, 2017].
97. Himmelstein D, Ursu O, Gilson M, Khankhanian P, Oprea T. 2016d. Incorporating DrugCentral data in our network. ThinkLab. https://doi.org/10.15363/thinklab.d186 [Accessed September 11, 2017].
98. Himmelstein D. 2015a. Incomplete Interactome licensing. ThinkLab. https://doi.org/10.15363/thinklab.d111 [Accessed September 11, 2017].
99. Himmelstein D. 2015b. Unifying drug vocabularies. ThinkLab. https://doi.org/10.15363/thinklab.d40 [Accessed September 11, 2017].
100. Himmelstein D. 2015c. Extracting side effects from SIDER 4. ThinkLab. https://doi.org/10.15363/thinklab.d97 [Accessed September 11, 2017].
101. Himmelstein D. 2015d. MSigDB licensing. ThinkLab. https://doi.org/10.15363/thinklab.d108 [Accessed September 11, 2017].
102. Himmelstein D. 2015e. Disease Ontology feature requests. ThinkLab. https://doi.org/10.15363/thinklab.d68 [Accessed September 11, 2017].
103. Himmelstein D. 2015f. janet piñero. Processing DisGeNET for disease-gene relationships. ThinkLab. https://doi. org/10.15363/thinklab.d105 [Accessed September 11, 2017].
104. Himmelstein D. 2015g. Functional disease annotations for genes using DOAF. ThinkLab. https://doi.org/10.15363/thinklab.d94 [Accessed September 11, 2017].
105. Himmelstein D. 2015h. Extracting disease-gene associations from the GWAS Catalog. ThinkLab. https://doi.org/10.15363/thinklab.d80 [Accessed September 11, 2017].
106. Himmelstein D. 2015i. Disease similarity from MEDLINE topic co-occurrence. ThinkLab. https://doi.org/10.15363/thinklab.d93 [Accessed September 11, 2017].
107. Himmelstein D. 2015j. Extracting indications from the ehrlink resource. ThinkLab. https://doi.org/10.15363/thinklab.d62 [Accessed September 11, 2017].
108. Himmelstein D. 2015k. LINCS L1000 licensing. ThinkLab. https://doi.org/10.15363/thinklab.d110 [Accessed September 11, 2017].
109. Himmelstein D. 2015l. Permuting hetnets and implementing randomized edge swaps in cypher. ThinkLab. https://doi.org/10.15363/thinklab.d136 [Accessed September 11, 2017].
110. Himmelstein D. 2015m. Using the neo4j graph database for hetnets. ThinkLab. https://doi.org/10.15363/thinklab.d112 [Accessed September 11, 2017].
111. Himmelstein D. 2015n. Assessing the informativeness of features. ThinkLab. https://doi.org/10.15363/thinklab. d115 [Accessed September 11, 2017].
112. Himmelstein D. 2016a. Announcing PharmacotherapyDB: the Open Catalog of Drug Therapies for Disease. ThinkLab. https://doi.org/10.15363/thinklab.d182 [Accessed September 11, 2017].
113. Himmelstein D. 2016b. Assessing the effectiveness of our hetnet permutations. ThinkLab. https://doi.org/10.15363/thinklab.d178 [Accessed September 11, 2017].
114. Himmelstein D. 2016c. Assessing the imputation quality of gene expression in LINCS L1000. ThinkLab. https://doi.org/10.15363/thinklab.d185 [Accessed September 11, 2017].
115. Himmelstein D. 2016d. Cataloging drug-disease therapies in the ClinicalTrials.gov database. ThinkLab. https://doi.org/10.15363/thinklab.d212 [Accessed September 11, 2017].
116. Himmelstein D. 2016e. Decomposing predictions into their network support. ThinkLab. https://doi.org/10.15363/thinklab.d229 [Accessed September 11, 2017].
117. Himmelstein D. 2016f. Decomposing the DWPC to assess intermediate node or edge contributions. ThinkLab. https://doi.org/10.15363/thinklab.d228 [Accessed September 11, 2017].
118. Himmelstein D. 2016g. dhimmel/hetio v0.2.0: Neo4j export, Cypher query creation, hetnet stats, and other enhancements. Zenodo. https://doi.org/10.5281/zenodo.61571
119. Himmelstein D. 2016h. Edge dropout contamination in hetnet edge prediction. ThinkLab. https://doi.org/10.15363/thinklab.d215 [Accessed September 11, 2017].
120. Himmelstein D. 2016i. Hosting Hetionet in the cloud: creating a public Neo4j instance. ThinkLab. https://doi.org/10.15363/thinklab.d216 [Accessed September 11, 2017].
121. Himmelstein D. 2016j. Exploring the power of Hetionet: a Cypher query depot. ThinkLab. https://doi.org/10.15363/thinklab.d220 [Accessed September 11, 2017].
122. Himmelstein D. 2016k. Our hetnet edge prediction methodology: the modeling framework for Project Rephetio. ThinkLab. https://doi.org/10.15363/thinklab.d210 [Accessed September 11, 2017].
123. Himmelstein D. 2017a. Dhimmel/Hetionet V1.0.0: Hetionet V1.0 In Json, Tsv, And Neo4J Formats. Zenodo. https://doi.org/10.5281/zenodo.268568
124. Himmelstein D. 2017b. Dhimmel/Learn V1.0: The Machine Learning Repository For Project Rephetio. Zenodo. https://doi.org/10.5281/zenodo.268654
125. Himmelstein D. 2017d. Why we predicted ictogenic tricyclic compounds treat epilepsy? ThinkLab. https://doi. org/10.15363/thinklab.d231 [Accessed September 11, 2017].
126. Himmelstein DS, Baranzini SE. 2015a. Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes. PLOS Computational Biology 11:e1004259. DOI: https://doi.org/10.1371/journal.pcbi.1004259, PMID: 26158728
127. Himmelstein DS, Baranzini SE. 2016b. Dhimmel/Gwas-Catalog V1.0: Extracting Gene-Disease Associations From The Gwas Catalog. Zenodo. https://doi.org/10.15363/thinklab.d80
128. Himmelstein DS, Baranzini SE. 2016e. Dhimmel/Ppi V1.0: Compiling A Human Protein Interaction Catalog. Zenodo. DOI: https://doi.org/10.5281/zenodo.48443
129. Himmelstein DS, Jensen LJ. 2016c. Dhimmel/Diseases V1.0: Processing The Diseases Database Of Gene-Disease Associations. Zenodo. https://doi.org/10.5281/zenodo.48427
130. Himmelstein DS, Khankhanian P, Hessler CS, Green AJ, Baranzini SE. 2016q. Dhimmel/Indications V1.0. Pharmacotherapydb: The Open Catalog Of Drug Therapies For Disease. Zenodo. DOI: https://doi.org/10.5281/zenodo.47664
131. Himmelstein DS, Lizee A, Hessler C, Brueggeman L, Chen SL, Hadley D, Green A, Khankhanian P, Baranzini SE. 2016u. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. bioRxiv. DOI: https://doi.org/10.1101/087619
132. Himmelstein DS, Piñero J. 2016d. Dhimmel/Disgenet V1.0: Processing The Disgenet Database Of Gene-Disease Associations. Zenodo. https://doi.org/10.5281/zenodo.48426
133. Himmelstein DS, Pico AR. 2016a. Dhimmel/Pathways V2.0: Compiling Human Pathway Gene Sets. Zenodo. https://doi.org/10.5281/zenodo.48810
134. Himmelstein DS. 2016g. User-Friendly Extensions To The Disease Ontology V1.0. Zenodo. https://doi.org/10.5281/zenodo.45584
135. Himmelstein DS. 2016h. User-Friendly Extensions To Mesh V1.0. Zenodo. https://doi.org/10.5281/zenodo.45586
136. Himmelstein DS. 2016i. User-Friendly Extensions Of The Drugbank Database V1.0. Zenodo. https://doi.org/10.5281/zenodo.45579
137. Himmelstein DS. 2016j. Extracting Tidy And User-Friendly Tsvs From Sider 4.1. Zenodo. https://doi.org/10.5281/zenodo.45521
138. Himmelstein DS. 2016l. Processed Entrez Gene Datasets For Humans V1.0. Zenodo. DOI: https://doi.org/10.5281/zenodo.45524
139. Himmelstein DS. 2016m. User-Friendly Anatomical Structures Data From The Uberon Ontology V1.0. Zenodo. DOI: https://doi.org/10.5281/zenodo.45527
140. Himmelstein DS. 2016s. Dhimmel/Doaf V1.0: Processing The Doaf Database Of Gene-Disease Associations. Zenodo. https://doi.org/10.5281/zenodo.48427
141. Himmelstein DS. 2016u. Dhimmel/Medline V1.0: Disease, Symptom, And Anatomy Cooccurence In Medline. Zenodo. https://doi.org/10.5281/zenodo.48445
142. Himmelstein DS. 2016w. Dhimmel/Erc V1.0: Processing Human Evolutionary Rate Covaration Data. Zenodo. DOI: https://doi.org/10.5281/zenodo.48444
143. Hodos RA, Kidd BA, Shameer K, Readhead BP, Dudley JT. 2016. In silico methods for drug repurposing and pharmacology. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 8:186-210. DOI: https://doi.org/10.1002/wsbm.1337, PMID: 27080087
144. Hopkins AL. 2007. Network pharmacology. Nature Biotechnology 25:1110-1111. DOI: https://doi.org/10.1038/nbt1007-1110, PMID: 17921993
145. Hopkins AL. 2008. Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 4: 682-690. DOI: https://doi.org/10.1038/nchembio.118, PMID: 18936753
146. Hrynaszkiewicz I, Cockerill MJ. 2012. Open by default: a proposed copyright license and waiver agreement for open access research and data in peer-reviewed journals. BMC Research Notes 5:494. DOI: https://doi.org/10.1186/1756-0500-5-494, PMID: 22958225
147. Hrynaszkiewicz I. 2011. The need and drive for open data in biomedical publishing. Serials: The Journal for the Serials Community 24:31-37. DOI: https://doi.org/10.1629/2431
148. Huntley RP, Sawford T, Mutowo-Meullenet P, Shypitsyna A, Bonilla C, Martin MJ, O’Donovan C. 2015. The GOA database: gene Ontology annotation updates for 2015. Nucleic Acids Research 43:D1057-D1063. DOI: https://doi.org/10.1093/nar/gku1113, PMID: 25378336
149. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P. 2013. Computational drug repositioning: from data to therapeutics. Clinical Pharmacology & Therapeutics 93:335-341. DOI: https://doi.org/10.1038/clpt.2013.1, PMID: 23443757
150. Iorio F, Rittman T, Ge H, Menden M, Saez-Rodriguez J. 2013. Transcriptional data: a new gateway to drug repositioning? Drug Discovery Today 18:350-357. DOI: https://doi.org/10.1016/j.drudis.2012.07.014, PMID: 22 897878
151. Iskar M, Zeller G, Zhao XM, van Noort V, Bork P. 2012. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. Current Opinion in Biotechnology 23:609-616. DOI: https://doi.org/10.1016/j.copbio.2011.11.010, PMID: 22153034
152. Jahromi SR, Togha M, Fesharaki SH, Najafi M, Moghadam NB, Kheradmand JA, Kazemi H, Gorji A. 2011. Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. Seizure 20:343-346. DOI: https://doi.org/10.1016/j.seizure.2010.12.011, PMID: 21236703
153. Jaiswal G. 2013. Comparative analysis of Relational and Graph databases. IOSR Journal of Engineering 03:25-27. DOI: https://doi.org/10.9790/3021-03822527
154. Johannessen Landmark C, Henning O, Johannessen SI. 2016. Proconvulsant effects of antidepressants-What is the current evidence? Epilepsy & Behavior 61:287-291. DOI: https://doi.org/10.1016/j.yebeh.2016.01.029, PMID: 26926001
155. Johannessen SI, Landmark CJ. 2010. Antiepileptic drug interactions-principles and clinical implications. Current Neuropharmacology 8:254. DOI: https://doi.org/10.2174/157015910792246254, PMID: 21358975
156. Khankhanian P, Himmelstein D. 2016. Prediction in epilepsy. ThinkLab. https://doi.org/10.15363/thinklab.d224 [Accessed September 11, 2017].
157. Khare R, Burger JD, Aberdeen JS, Tresner-Kirsch DW, Corrales TJ, Hirchman L, Lu Z. 2015. Scaling drug indication curation through crowdsourcing. Database 2015:bav016. DOI: https://doi.org/10.1093/database/bav016, PMID: 25797061
158. Khare R, Li J, Lu Z. 2014. LabeledIn: cataloging labeled indications for human drugs. Journal of Biomedical Informatics 52:448-456. DOI: https://doi.org/10.1016/j.jbi.2014.08.004, PMID: 25220766
159. Kibbe WA, Arze C, Felix V, Mitraka E, Bolton E, Fu G, Mungall CJ, Binder JX, Malone J, Vasant D, Parkinson H, Schriml LM. 2015. Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Research 43:D1071-D1078. DOI: https://doi.org/10.1093/nar/gku1011, PMID: 25348409
160. Kivela M, Arenas A, Barthelemy M, Gleeson JP, Moreno Y, Porter MA. 2014. Multilayer networks. Journal of Complex Networks 2:203-271. DOI: https://doi.org/10.1093/comnet/cnu016
161. Knaus K. 2016. Anatomical Therapeutic Chemical Classification System (WHO). In: The SAGE Encyclopedia of Pharmacology and Society. DOI: https://doi.org/10.4135/9781483349985.n37
162. Kuhn M, Letunic I, Jensen LJ, Bork P. 2016. The SIDER database of drugs and side effects. Nucleic Acids Research 44:D1075-D1079. DOI: https://doi.org/10.1093/nar/gkv1075
163. Kutmon M, Riutta A, Nunes N, Hanspers K, Willighagen EL, Bohler A, Mélius J, Waagmeester A, Sinha SR, Miller R, Coort SL, Cirillo E, Smeets B, Evelo CT, Pico AR. 2016. WikiPathways: capturing the full diversity of pathway knowledge. Nucleic Acids Research 44:D488-D494. DOI: https://doi.org/10.1093/nar/gkv1024, PMID: 264 81357
164. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-1935. DOI: https://doi.org/10.1126/science.1132939, PMID: 17008526
165. Lamb J. 2007. The Connectivity Map: a new tool for biomedical research. Nature Reviews Cancer 7:54-60. DOI: https://doi.org/10.1038/nrc2044, PMID: 17186018
166. Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS. 2014. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Research 42:D1091-D1097. DOI: https://doi.org/10.1093/nar/gkt1068, PMID: 24203711
167. Li J, Lu Z. 2012. A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity. Proceedings. IEEE International Conference on Bioinformatics and Biomedicine 2012:1-4. DOI: https://doi.org/10.1109/BIBM.2012.6392722, PMID: 25264495
168. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdó ttir H, Tamayo P, Mesirov JP. 2011. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27:1739-1740. DOI: https://doi.org/10.1093/bioinformatics/btr260, PMID: 21546393
169. Liu Z, Fang H, Reagan K, Xu X, Mendrick DL, Slikker W, Tong W. 2013. In silico drug repositioning-what we need to know. Drug Discovery Today 18:110-115. DOI: https://doi.org/10.1016/j.drudis.2012.08.005
170. Lizee A, Himmelstein D. 2016a. Network Edge Prediction: Estimating the prior. ThinkLab. https://doi.org/10.15363/thinklab.d201 [Accessed September 11, 2017].
171. Lizee A, Himmelstein D. 2016b. Network Edge Prediction: how to deal with self-testing. ThinkLab. https://doi. org/10.15363/thinklab.d194 [Accessed September 11, 2017].
172. Lysenko A, Roznovaţ IA, Saqi M, Mazein A, Rawlings CJ, Auffray C. 2016. Representing and querying disease networks using graph databases. BioData Mining 9:23. DOI: https://doi.org/10.1186/s13040-016-0102-8, PMID: 27462371
173. MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, Pendlington ZM, Welter D, Burdett T, Hindorff L, Flicek P, Cunningham F, Parkinson H. 2017. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Research 45:D896-D901. DOI: https://doi.org/10.1093/nar/gkw1133, PMID: 27899670
174. Maglott D, Ostell J, Pruitt KD, Tatusova T. 2011. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Research 39:D52-D57. DOI: https://doi.org/10.1093/nar/gkq1237, PMID: 21115458
175. Malladi V, Himmelstein D, Mungall C. 2015. Tissue node. ThinkLab. https://doi.org/10.15363/thinklab.d41 [Accessed September 11, 2017].
176. Malone J, Stevens R, Jupp S, Hancocks T, Parkinson H, Brooksbank C. 2016. Ten simple rules for selecting a bio-ontology. PLOS Computational Biology 12:e1004743. DOI: https://doi.org/10.1371/journal.pcbi.1004743, PMID: 26867217
177. McCoy AB, Wright A, Laxmisan A, Ottosen MJ, McCoy JA, Butten D, Sittig DF. 2012. Development and evaluation of a crowdsourcing methodology for knowledge base construction: identifying relationships between clinical problems and medications. Journal of the American Medical Informatics Association 19:713-718. DOI: https://doi.org/10.1136/amiajnl-2012-000852, PMID: 22582202
178. McKiernan EC, Bourne PE, Brown CT, Buck S, Kenall A, Lin J, McDougall D, Nosek BA, Ram K, Soderberg CK, Spies JR, Thaney K, Updegrove A, Woo KH, Yarkoni T. 2016. How open science helps researchers succeed. eLife 5:16800. DOI: https://doi.org/10.7554/eLife.16800
179. Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barabá si AL. 2015. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347:1257601. DOI: https://doi.org/10.1126/science.1257601, PMID: 25700523
180. Mietchen D, Mounce R, Penev L. 2015. Publishing the research process. Research Ideas and Outcomes 1:e7547. DOI: https://doi.org/10.3897/rio.1.e7547
181. Mihalak KB, Carroll FI, Luetje CW. 2006. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology 70:801-805. DOI: https://doi.org/10.1124/mol. 106.025130, PMID: 16766716
182. Mirsattari SM, Sharpe MD, Young GB. 2004. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Archives of Neurology 61:1254. DOI: https://doi.org/10.1001/archneur.61.8.1254, PMID: 15313843
183. Molloy JC. 2011. The open knowledge foundation: open data means better science. PLoS Biology 9:e1001195. DOI: https://doi.org/10.1371/journal.pbio.1001195, PMID: 22162946
184. Morgan HL. 1965. The generation of a unique machine description for chemical structures-a technique developed at chemical abstracts service. Journal of Chemical Documentation 5:107-113. DOI: https://doi.org/10.1021/c160017a018
185. Mungall CJ, McMurry JA, Köhler S, Balhoff JP, Borromeo C, Brush M, Carbon S, Conlin T, Dunn N, Engelstad M, Foster E, Gourdine JP, Jacobsen JO, Keith D, Laraway B, Lewis SE, NguyenXuan J, Shefchek K, Vasilevsky N, Yuan Z, et al. 2017. The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Research 45:D712-D722. DOI: https://doi.org/10.1093/nar/gkw1128, PMID: 27899636
186. Mungall CJ, Torniai C, Gkoutos GV, Lewis SE, Haendel MA. 2012. Uberon, an integrative multi-species anatomy ontology. Genome Biology 13:R5. DOI: https://doi.org/10.1186/gb-2012-13-1-r5, PMID: 22293552
187. Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J, Cardon LR, Whittaker JC, Sanseau P. 2015. The support of human genetic evidence for approved drug indications. Nature Genetics 47:856-860. DOI: https://doi.org/10.1038/ng.3314
188. Nugent T, Plachouras V, Leidner JL. 2016. Computational drug repositioning based on side-effects mined from social media. PeerJ Computer Science 2:e46. DOI: https://doi.org/10.7717/peerj-cs.46
189. Oxenham S. 2016. Legal confusion threatens to slow data science. Nature 536:16-17. DOI: https://doi.org/10.1038/536016a, PMID: 27488781
190. Patil C, Siegel V. 2009. This revolution will be digitized: online tools for radical collaboration. Disease Models & Mechanisms 2:201-205. DOI: https://doi.org/10.1242/dmm.003285, PMID: 19407323
191. Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, García-García J, Sanz F, Furlong LI. 2017. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Research 45:D833-D839. DOI: https://doi.org/10.1093/nar/gkw943, PMID: 27924018
192. Piñero J, Queralt-Rosinach N, Bravo À, Deu-Pons J, Bauer-Mehren A, Baron M, Sanz F, Furlong LI. 2015. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database 2015:bav028. OI: https://doi.org/10.1093/database/bav028, PMID: 25877637
193. Pico A, Himmelstein D. 2015. Adding pathway resources to your network. ThinkLab. https://doi.org/10.15363/thinklab.d72 [Accessed September 11, 2017].
194. Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C. 2008.
195. WikiPathways: pathway editing for the people. PLoS biology 6:e184. DOI: https://doi.org/10.1371/journal.pbio.0060184, PMID: 18651794
196. Piwowar HA, Vision TJ. 2013. Data reuse and the open data citation advantage. PeerJ 1:e175. DOI: https://doi. org/10.7717/peerj.175, PMID: 24109559
197. Placidi F, Scalise A, Marciani MG, Romigi A, Diomedi M, Gigli GL. 2000. Effect of antiepileptic drugs on sleep. Clinical Neurophysiology 111:S115-S119. DOI: https://doi.org/10.1016/S1388-2457(00)00411-9, PMID: 10 996564
198. Pletscher-Frankild S, Pallejà A, Tsafou K, Binder JX, Jensen LJ. 2015. DISEASES: text mining and data integration of disease-gene associations. Methods 74:83-89. DOI: https://doi.org/10.1016/j.ymeth.2014.11. 020, PMID: 25484339
199. Powell K. 2016. Does it take too long to publish research? Nature 530:148-151. DOI: https://doi.org/10.1038/530148a
200. Pratanwanich N, Lió P. 2014. Pathway-based Bayesian inference of drug-disease interactions. Mol. BioSyst. 10: 1538-1548. DOI: https://doi.org/10.1039/C4MB00014E, PMID: 24695945
201. Priedigkeit N, Wolfe N, Clark NL. 2015. Evolutionary signatures amongst disease genes permit novel methods for gene prioritization and construction of informative gene-based networks. PLOS Genetics 11:e1004967. DOI: https://doi.org/10.1371/journal.pgen.1004967, PMID: 25679399
202. Qu XA, Rajpal DK. 2012. Applications of connectivity map in drug discovery and development. Drug Discovery Today 17:1289-1298. DOI: https://doi.org/10.1016/j.drudis.2012.07.017, PMID: 22889966
203. Reichert JM. 2003. Trends in development and approval times for new therapeutics in the United States. Nature Reviews Drug Discovery 2:695-702. DOI: https://doi.org/10.1038/nrd1178, PMID: 12951576
204. Rogawski MA, Löscher W. 2004. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience 5:553-564. DOI: https://doi.org/10.1038/nrn1430, PMID: 15208697
205. Rogers D, Hahn M. 2010. Extended-connectivity fingerprints. Journal of Chemical Information and Modeling 50: 742-754. DOI: https://doi.org/10.1021/ci100050t, PMID: 20426451
206. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, et al. 2014. A proteome-scale map of the human interactome network. Cell 159:1212-1226. DOI: https://doi.org/10.1016/j.cell.2014.10.050, PMID: 25416956
207. Roth BL, Sheffler DJ, Kroeze WK. 2004. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nature Reviews Drug Discovery 3:353-359. DOI: https://doi.org/10.1038/nrd1346, PMID: 15060530
208. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, et al. 2005. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437:1173-1178. DOI: https://doi.org/10.1038/nature04209, PMID: 16189514
209. Sanseau P, Agarwal P, Barnes MR, Pastinen T, Richards JB, Cardon LR, Mooser V. 2012. Use of genome-wide association studies for drug repositioning. Nature Biotechnology 30:317-320. DOI: https://doi.org/10.1038/nbt.2151, PMID: 22491277
210. Santos A, Tsafou K, Stolte C, Pletscher-Frankild S, O’Donoghue SI, Jensen LJ. 2015. Comprehensive comparison of large-scale tissue expression datasets. PeerJ 3:e1054. DOI: https://doi.org/10.7717/peerj.1054, PMID: 26157623
211. Sawcer S. 2008. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 131:3118-3131. DOI: https://doi.org/10.1093/brain/awn081, PMID: 18490360
212. Scannell JW, Blanckley A, Boldon H, Warrington B. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews. Drug Discovery 11:191. DOI: https://doi.org/10.1038/nrd3681, PMID: 22378269
213. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. 2009. PID: the pathway interaction database. Nucleic Acids Research 37:D674-D679. DOI: https://doi.org/10.1093/nar/gkn653
214. Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, Felix V, Feng G, Kibbe WA. 2012. Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Research 40:D940-D946. DOI: https://doi.org/10.1093/nar/gkr972, PMID: 22080554
215. Shameer K, Glicksberg BS, Hodos R, Johnson KW, Badgeley MA, Readhead B, Tomlinson MS, O’Connor T, Miotto R, Kidd BA, Chen R, Ma’ayan A, Dudley JT. 2017. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning. Briefings in Bioinformatics:bbw136. DOI: https://doi.org/10.1093/bib/bbw136
216. Sharp ME. 2017. Toward a comprehensive drug ontology: extraction of drug-indication relations from diverse information sources. Journal of Biomedical Semantics 8:2. DOI: https://doi.org/10.1186/s13326-016-0110-0, PMID: 28069052
217. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ. 2011. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine 3:96ra77. DOI: https://doi.org/10.1126/scitranslmed.3001318, PMID: 21849665
218. Spaulding J, Himmelstein D, Greene C, Good B. 2015. Enabling reproducibility and reuse. ThinkLab. https://doi. org/10.15363/thinklab.d23 [Accessed September 11, 2017].
219. Stephens M, Balding DJ. 2009. Bayesian statistical methods for genetic association studies. Nature Reviews Genetics 10:681-690. DOI: https://doi.org/10.1038/nrg2615, PMID: 19763151
220. Stodden V, McNutt M, Bailey DH, Deelman E, Gil Y, Hanson B, Heroux MA, Ioannidis JP, Taufer M. 2016. Enhancing reproducibility for computational methods. Science 354:1240-1241. DOI: https://doi.org/10.1126/science.aah6168, PMID: 27940837
221. Stodden V, Miguez S. 2014. Best practices for computational science: software infrastructure and environments for reproducible and extensible research. Journal of Open Research Software 2:e21. DOI: https://doi.org/10.5334/jors.ay
222. Summer G, Kelder T, Radonjic M, van Bilsen M, Wopereis S, Heymans S. 2016. The network library: a framework to rapidly integrate network biology resources. Bioinformatics 32:i473-i478. DOI: https://doi.org/10.1093/bioinformatics/btw436, PMID: 27587664
223. Sun Y, Barber R, Gupta M, Aggarwal CC, Jiawei H. 2011. Co-author relationship prediction in heterogeneous bibliographic networks. 2011 International Conference on Advances in Social Networks Analysis and Mining: 121-128.
224. Swinney DC, Anthony J. 2011. How were new medicines discovered? Nature Reviews Drug Discovery 10:507-519. DOI: https://doi.org/10.1038/nrd3480, PMID: 21701501
225. Tatonetti NP, Ye PP, Daneshjou R, Altman RB. 2012. Data-driven prediction of drug effects and interactions. Science Translational Medicine 4:125ra31. DOI: https://doi.org/10.1126/scitranslmed.3003377, PMID: 22422 992
226. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, et al. 2008. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638-642. DOI: https://doi.org/10.1038/nature06846, PMID: 18385739
227. Ursu O, Holmes J, Knockel J, Bologa CG, Yang JJ, Mathias SL, Nelson SJ, Oprea TI. 2017. DrugCentral: online drug compendium. Nucleic Acids Research 45:D932-D939. DOI: https://doi.org/10.1093/nar/gkw993, PMID: 27789690
228. Vale RD. 2015. Accelerating scientific publication in biology. PNAS 112:13439-13446. DOI: https://doi.org/10.1073/pnas.1511912112, PMID: 26508643
229. Venkatesan K, Rual J-F, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh K-I, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet A-S, Dann E, Smolyar A, et al. 2009. An empirical framework for binary interactome mapping. Nature Methods 6:83-90. DOI: https://doi.org/10.1038/nmeth.1280
230. Waldrop MM. 2015. Why we are teaching science wrong, and how to make it right. Nature 523:272-274. DOI: https://doi.org/10.1038/523272a, PMID: 26178948
231. Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C. 2014. Cytisine versus nicotine for smoking cessation. New England Journal of Medicine 371:2353-2362. DOI: https://doi.org/10.1056/NEJMoa1407764, PMID: 25517706
232. Wang G, Jung K, Winnenburg R, Shah NH. 2015. A method for systematic discovery of adverse drug events from clinical notes. Journal of the American Medical Informatics Association 22:1196-1204. DOI: https://doi.org/10.1093/jamia/ocv102
233. Wei WQ, Cronin RM, Xu H, Lasko TA, Bastarache L, Denny JC. 2013. Development and evaluation of an ensemble resource linking medications to their indications. Journal of the American Medical Informatics Association 20:954-961. DOI: https://doi.org/10.1136/amiajnl-2012-001431, PMID: 23576672
234. West R, Zatonski W, Cedzynska M, Lewandowska D, Pazik J, Aveyard P, Stapleton J. 2011. Placebo-controlled trial of cytisine for smoking cessation. New England Journal of Medicine 365:1193-1200. DOI: https://doi.org/10.1056/NEJMoa1102035, PMID: 21991893
235. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. 2006. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research 34:D668-D672. DOI: https://doi.org/10.1093/nar/gkj067, PMID: 16381955
236. Wu D, Thijs RD. 2015. Anticonvulsant-induced downbeat nystagmus in epilepsy. Epilepsy & Behavior Case Reports 4:74-75. DOI: https://doi.org/10.1016/j.ebcr.2015.07.003, PMID: 26543808
237. Wu TJ, Schriml LM, Chen QR, Colbert M, Crichton DJ, Finney R, Hu Y, Kibbe WA, Kincaid H, Meerzaman D, Mitraka E, Pan Y, Smith KM, Srivastava S, Ward S, Yan C, Mazumder R. 2015. Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis. Database: The Journal of Biological Databases and Curation 2015:bav032. DOI: https://doi.org/10.1093/database/bav032, PMID: 25 841438
238. Xu H, Aldrich MC, Chen Q, Liu H, Peterson NB, Dai Q, Levy M, Shah A, Han X, Ruan X, Jiang M, Li Y, Julien JS, Warner J, Friedman C, Roden DM, Denny JC. 2015. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. Journal of the American Medical Informatics Association: JAMIA 22:179-191. DOI: https://doi.org/10.1136/amiajnl-2014-002649, PMID: 25053577
239. Xu W, Wang H, Cheng W, Fu D, Xia T, Kibbe WA, Lin SM. 2012. A framework for annotating human genome in disease context. PLoS One 7:e49686. DOI: https://doi.org/10.1371/journal.pone.0049686, PMID: 23251346
240. Yoon BH, Kim SK, Kim SY. 2017. Use of graph database for the integration of heterogeneous biological data. Genomics & Informatics 15:19. DOI: https://doi.org/10.5808/GI.2017.15.1.19, PMID: 28416946
241. Yu H, Tardivo L, Tam S, Weiner E, Gebreab F, Fan C, Svrzikapa N, Hirozane-Kishikawa T, Rietman E, Yang X, Sahalie J, Salehi-Ashtiani K, Hao T, Cusick ME, Hill DE, Roth FP, Braun P, Vidal M. 2011. Next-generation sequencing to generate interactome datasets. Nature Methods 8:478-480. DOI: https://doi.org/10.1038/nmeth.1597, PMID: 21516116
242. Zadikoff C, Munhoz RP, Asante AN, Politzer N, Wennberg R, Carlen P, Lang A. 2007. Movement disorders in patients taking anticonvulsants. Journal of Neurology, Neurosurgery & Psychiatry 78:147-151. DOI: https://doi. org/10.1136/jnnp.2006.100222, PMID: 17012337
243. Zhou X, Menche J, Barabá si AL, Sharma A. 2014. Human symptoms-disease network. Nature Communications 5: 4212. DOI: https://doi.org/10.1038/ncomms5212, PMID: 24967666